FIBROCELL SCIENCE, INC.
Profile
Company Names
FIBROCELL SCIENCE, INC.
Addresses
405 EAGLEVIEW BOULEVARD, EXTON, PA 19341
Phone Numbers
484-713-6000
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$113,512,789.00
Number of Funding Rounds:
11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2018-12-07
$900,000.00
$900,000.00
$0.00
Equity
10
2018-07-02
$3,064,216.00
$3,064,216.00
$0.00
9
2018-05-29
$5,087,980.00
$5,087,980.00
$0.00
8
2016-08-09
$17,625,000.00
$25,000,000.00
$7,375,000.00
Debt
7
2012-10-09
$45,000,000.00
$45,000,000.00
$0.00
Equity
6
2012-05-14
$3,353,000.00
$12,000,000.00
$8,647,000.00
Equity
5
2011-08-03
$22,800,000.00
$22,800,000.00
$0.00
Equity
4
2010-12-08
$4,293,000.00
$7,800,000.00
$3,507,000.00
3
2010-07-19
$2,702,000.00
$2,702,000.00
$0.00
Equity
2
2010-03-04
$3,807,500.00
$3,807,500.00
$0.00
Equity
1
2009-10-13
$4,880,093.00
$4,880,093.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT
LANGER
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ALSERES PHARMACEUTICALS INC /DE
| ECHO THERAPEUTICS, INC.
| MICELL TECHNOLOGIES INC
| CERULEAN PHARMA INC.
| HUMACYTE INC
| COMBINENT BIOMEDICAL SYSTEMS, INC.
| TARIS BIOMEDICAL INC
| KALA PHARMACEUTICALS, INC.
| FIBROCELL SCIENCE, INC.
| PREDICTIVE BIOSCIENCES, INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| SEMPRUS BIOSCIENCES CORP
| LIQUIDX, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| SELECTA BIOSCIENCES INC
| STEMNION, INC.
| 480 BIOMEDICAL, INC.
| LIVING PROOF INC
| DX BIOSCIENCES, INC.
| MODERNA LLC
| HUMACYTE, INC
| XTUIT PHARMACEUTICALS, INC.
| SQZ BIOTECHNOLOGIES CO
| NOVEOME BIOTHERAPEUTICS, INC.
| LYNDRA, INC.
| MODERNA THERAPEUTICS, INC.
| VERSEAU THERAPEUTICS, INC.
| FREQUENCY THERAPEUTICS, INC.
| SUONO BIO, INC.
| COMBINED THERAPEUTICS, INC.
| HUMACYTE, INC.
| SEER BIOSCIENCES, INC.
| LANDSDOWNE LABS, LLC
| LIKEMINDS, INC./DE
| TARVEDA THERAPEUTICS, INC.
| LUMINOPIA, INC.
| LYRA THERAPEUTICS, INC.
| ABPRO CORP
| GLYMPSE BIO, INC.
| EPIBONE, INC.
| TEAL BIO, INC.
| ZWI THERAPEUTICS, INC.
| LYNDRA THERAPEUTICS, INC.
| KENDALL CAPITAL PARTNERS I, L.P.
| BILAYER THERAPEUTICS, INC.
| XENTER, INC.
| VIVTEX CORP
| SYNTIS BIO, INC.
| OMNIPULSE BIOSCIENCES, INC.
MARCUS
SMITH
DIRECTOR
DOUGLAS
J.
SWIRSKY
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-12-07
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2016-08-09
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2012-10-09
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2012-05-14
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2011-08-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Equity
2010-07-19
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Equity
2009-10-13
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Equity
2010-03-04
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
